Residual Thrombosis: Still Relevant in the Direct Oral Anticoagulant (DOAC) Era?

Thromb Haemost. 2023 Aug;123(8):747-749. doi: 10.1055/a-2102-0376. Epub 2023 May 26.

Authors

Cecilia Becattini¹, Giancarlo Agnelli¹

Affiliation

¹ Internal and Cardiovascular Medicine, Stroke Unit, University of Perugia, Perugia, Italy.

PMID: 37236228
DOI: 10.1055/a-2102-0376

No abstract available

MeSH terms

Administration, Oral
Anticoagulants / adverse effects
Humans
Thrombosis* / drug therapy
Thrombosis* / prevention & control

Substances

Anticoagulants